Neuroone Medical Technologies Corp (NMTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Sales | 12,098 | 3,453 | 3,408 | 2,120 | 243 |
| Cost of Goods | 3,956 | 2,373 | 1,496 | 242 | 276 |
| Gross Profit | 8,141 | 1,080 | 1,912 | 1,878 | -33 |
| Operating Expenses | 13,324 | 13,340 | 14,363 | 12,151 | 10,461 |
| Operating Income | -4,227 | -11,887 | -11,955 | -10,031 | -10,218 |
| Interest Expense | 0 | 0 | 0 | 0 | 3 |
| Other Income | 621 | -431 | 96 | 31 | 273 |
| Pre-tax Income | -3,605 | -12,318 | -11,860 | -10,000 | -9,948 |
| Net Income Continuous | -3,605 | -12,318 | -11,860 | -10,000 | -9,948 |
| Net Income | $-3,605 | $-12,318 | $-11,860 | $-10,000 | $-9,948 |
| EPS Basic Total Ops | -0.09 | -0.46 | -0.65 | -0.63 | -0.93 |
| EPS Basic Continuous Ops | -0.09 | -0.46 | -0.65 | -0.63 | -0.93 |
| EPS Diluted Total Ops | -0.09 | -0.46 | -0.65 | -0.63 | -0.93 |
| EPS Diluted Continuous Ops | -0.09 | -0.46 | -0.65 | -0.63 | -0.93 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.46 | -0.65 | -0.63 | -0.93 |
| EBITDA(a) | $-3,772 | $-11,539 | $-11,802 | $-9,924 | $-10,138 |